Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 07, 2024

BUY
$9.99 - $14.91 $4.87 Million - $7.27 Million
487,300 Added 1613.58%
517,500 $7.25 Million
Q4 2023

Feb 14, 2024

BUY
$7.6 - $10.53 $118,560 - $164,268
15,600 Added 106.85%
30,200 $318,000
Q3 2023

Nov 14, 2023

SELL
$7.15 - $10.2 $192,335 - $274,380
-26,900 Reduced 64.82%
14,600 $133,000
Q2 2023

Aug 11, 2023

BUY
$7.23 - $10.52 $219,069 - $318,756
30,300 Added 270.54%
41,500 $301,000
Q1 2023

May 16, 2023

SELL
$7.81 - $11.05 $110,902 - $156,910
-14,200 Reduced 55.91%
11,200 $94,000
Q4 2022

Feb 14, 2023

SELL
$6.52 - $8.95 $441,404 - $605,915
-67,700 Reduced 72.72%
25,400 $190,000
Q3 2022

Nov 14, 2022

BUY
$7.76 - $13.72 $509,056 - $900,032
65,600 Added 238.55%
93,100 $749,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.